ConductScience.org, home

Paper28636634

Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril.

Mitręga KA and 5 others. PLoS One, 2017. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril. Papers, record 28636634. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28636634

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril.
PubMed
Journal
PLoS One
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.13
iCite
Revised in PubMed
2024-03-26
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mitręga KAKatarzyna A
2Spałek AMAdrianna M
3Nożyński JJerzy
4Porc MMaurycy
5Stankiewicz MMagdalena
6Krzemiński TFTadeusz F

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiotensin-Converting Enzyme InhibitorsMajor topic
CaptoprilMajor topic
CardiomyopathiesMajor topic
DihydropyridinesMajor topic
Myocardial InfarctionMajor topic
Administration, Oral
Animals
Biomarkers
Blood Pressure
Disease Models, Animal
Heart
Heart Rate
Hemodynamics
Male
Myocardium
Rats
Rats, Sprague-Dawley

Source PubMed

Download CSV of topics

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118071079Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.Circulation2008https://conductscience.org/library/papers/18071079PubMed
26831647Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.Circ Res1983https://conductscience.org/library/papers/6831647PubMed
36024443Effect of pressure development on oxygen consumption by isolated rat heart.Am J Physiol1967https://conductscience.org/library/papers/6024443PubMed
47723356Effects of chronic angiotensin I-converting enzyme inhibition on the relations between ventricular action potential changes and myocardial hypertrophy in aging rats.J Cardiovasc Pharmacol1995https://conductscience.org/library/papers/7723356PubMed
53300384A classification of cardiac allograft rejection. A modification of the classification by Billingham.Am J Surg Pathol1987https://conductscience.org/library/papers/3300384PubMed
62581092Effects of nisoldipine, a new calcium antagonist, on myocardial infarct size and cardiac dynamics following acute myocardial infarction.J Cardiovasc Pharmacol1985https://conductscience.org/library/papers/2581092PubMed
77841090How do calcium antagonists differ in clinical practice?Cardiovasc Drugs Ther1994https://conductscience.org/library/papers/7841090PubMed
87512465Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle.Drugs1993https://conductscience.org/library/papers/7512465PubMed
92434754Ischemia- and reperfusion-induced arrhythmias: beneficial actions of nifedipine.J Cardiovasc Pharmacol1986https://conductscience.org/library/papers/2434754PubMed
1013783530Anaesthesia in new-born animals.Br J Pharmacol Chemother1960https://conductscience.org/library/papers/13783530PubMed
113049090Angiotensin converting enzyme inhibitors and ischaemic heart disease.Eur Heart J1988https://conductscience.org/library/papers/3049090PubMed
129049514Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.Eur Heart J1997https://conductscience.org/library/papers/9049514PubMed
1316043419Angiogenesis and cardioprotection after TNFalpha-inducer-Tolpa Peat Preparation treatment in rat's hearts after experimental myocardial infarction in vivo.Vascul Pharmacol2005https://conductscience.org/library/papers/16043419PubMed
142427810Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498.J Cardiovasc Pharmacol1986https://conductscience.org/library/papers/2427810PubMed
152151900Early ventricular remodeling after myocardial damage and its attenuation by converting enzyme inhibition.Trans Assoc Am Physicians1990https://conductscience.org/library/papers/2151900PubMed
1621052014Cardioprotective effects of an active metabolite of furnidipine in 2 models of isolated heart and on in vivo ischemia–induced and reperfusion-induced arrhythmias in rats.J Cardiovasc Pharmacol2011https://conductscience.org/library/papers/21052014PubMed
1713749954Simple techniques for the surgical occlusion of coronary vessels in the rat.Angiology1960https://conductscience.org/library/papers/13749954PubMed
1826320110
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).
Eur Heart J2016https://conductscience.org/library/papers/26320110PubMed
192397747Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist.Eur J Pharmacol1990https://conductscience.org/library/papers/2397747PubMed
2010900218Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels.J Pharmacol Exp Ther2000https://conductscience.org/library/papers/10900218PubMed

See all 54 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
40806350Cardioprotective Role of Captopril: From Basic to Applied Investigations.Int J Mol Sci2025https://conductscience.org/library/papers/40806350PubMed
35861038Pirfenidone alleviates cardiac fibrosis induced by pressure overload via inhibiting TGF-β1/Smad3 signalling pathway.J Cell Mol Med2022https://conductscience.org/library/papers/35861038PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28636634

GET https://conductscience.org/api/papers/v1/28636634/references?page=2